Publications by authors named "Sandra Croockewit"

Claim this Profile
M
Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple Myeloma.
Charissa Wijnands, Peter G A Karel, Jolein Gloerich, Gad Armony, Anastasia Tzasta, Sandra J Croockewit

Pharmaceutics· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial.
Elias K Mai, Axel Nogai, Henk M Lokhorst, Bronno van der Holt, Sonja Zweegman, Sandra Croockewit

Hemasphere· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.
Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula F Ypma, Ka Lung Wu, Sandra Croockewit

EJHaem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Kalijn F Bol, Gerty Schreibelt, Martine Bloemendal, Wouter W van Willigen, Simone Hins-de Bree, Sandra J Croockewit

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma.
Madeleine R Berendsen, Diede A G van Bladel, Eva Hesius, Cristina Berganza Irusquieta, Jos Rijntjes, Sandra Croockewit

Hemasphere· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological responses to adjuvant vaccination with combined CD1c myeloid and plasmacytoid dendritic cells in stage III melanoma patients.
Martine Bloemendal, Kalijn F Bol, Steve Boudewijns, Mark A J Gorris, Johannes H W de Wilt, Sandra A J Croockewit

Oncoimmunology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma.
Pieter Sonneveld, Sonja Zweegman, Michele Cavo, Kazem Nasserinejad, Annemiek Broijl, Sandra Croockewit

Hemasphere· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry.
Ruth Wester, Avinash G Dinmohamed, Bronno van der Holt, Sonja Zweegman, Monique Minnema, Sandra Croockewit

Hemasphere· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial.
Monique C Minnema, Kazem Nasserinejad, Bouke Hazenberg, Ute Hegenbart, Philip Vlummens, Sandra Croockewit

Haematologica· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal involvement in amyloidosis is a sequential process.
Marjanne den Braber-Ymker, Sanneke Heijker, Martin Lammens, Sandra Croockewit, Iris D Nagtegaal

Neurogastroenterol Motil· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.
Niels Wcj van de Donk, Bronno van der Holt, Monique C Minnema, Edo Vellenga, Sandra Croockewit

Lancet Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical validation of the Hevylite assays for M-protein quantification.
Joannes F M Jacobs, Inez-Anne Haagen, Astrid Lodder, Cieleke van der Kroft, Corrie M de Kat Angelino, Sandra Croockewit

Clin Chem Lab Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Joannes F M Jacobs, Corrie M de Kat Angelino, Huberdina M L M Brouwers, Sandra A Croockewit, Irma Joosten

Clin Chem Lab Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
Anja van Oostrum, Jaap Jan Zwaginga, Sandra Croockewit, Jacqueline Overdevest, Mirjam Fechter

J Clin Apher· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
Kalijn F Bol, Thomas van den Bosch, Gerty Schreibelt, Hanneke W Mensink, Jan E E Keunen, Sandra A J Croockewit

Ophthalmology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).
Niels W C J van de Donk, Henny G Otten, Omar El Haddad, Amy Axel, A Kate Sasser, Sandra Croockewit

Clin Chem Lab Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells.
Gerty Schreibelt, Kalijn F Bol, Harm Westdorp, Florian Wimmers, Erik H J G Aarntzen, Sandra A J Croockewit

Clin Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
Kalijn F Bol, Erik H J G Aarntzen, Jeanette M Pots, Michel A M Olde Nordkamp, Mandy W M M van de Rakt, Sandra A J Croockewit

Cancer Immunol Immunother· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients.
Kalijn F Bol, Carl G Figdor, Erik Hjg Aarntzen, Marieke Eb Welzen, Michelle M van Rossum, Sandra Aj Croockewit

Oncoimmunology· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Christof Scheid, Pieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Sandra Croockewit

Haematologica· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.
Jurjen Tel, Erik H J G Aarntzen, Tetsuro Baba, Gerty Schreibelt, Barbara M Schulte, Sandra Croockewit

Cancer Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma.
Marian Stevens-Kroef, Daniel Olde Weghuis, Sandra Croockewit, Leo Derksen, Jeroen Hooijer

Genes Chromosomes Cancer· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
Julien Haroche, Frédéric Charlotte, Laurent Arnaud, Andreas von Deimling, Zofia Hélias-Rodzewicz, Sandra Croockewit

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
W Joost Lesterhuis, I Jolanda M de Vries, Gerty Schreibelt, Annechien J A Lambeck, Erik H J G Aarntzen, Sandra Croockewit

Clin Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
W Joost Lesterhuis, Gerty Schreibelt, Nicole M Scharenborg, H Mary-lène H Brouwer, Marie-Jeanne P Gerritsen, Sandra Croockewit

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis